Latest Developments in Impurity Synthesis

TENELIGLIPTIN IMPURITIES AVAILABLE IN KARPSCHEM

NABUMETONE IMPURITIES AVAILABLE IN KARPSCHEM

FEBUXOSTAT IMPURITY AVAILABLE IN KARPSCHEM

Olmesartan Impurities and New Development in API Impurities Featured In-stock in KarpsChem

Dabigratan Impurities Available in KarpsChem

Estradiol for Human Hormonal Health

Estradiol, also spelled oestradiol, is an estrogen steroid hormone and the major female sex hormone. It is involved in the regulation of the estrous and menstrual female reproductive cycles. Removal of impurity is an integral part of drug manufacturing process. KarpsChem devote its dedicated customer in order to maintain integrity of impurities. Estradiol impurities are available in KarpsChem.

KarpsChem regarded as an leading manufacturer of KSM and Pharmacopoeia impurities available with COA & analysis. Please let us know your requirements. We will be happy to fulfill your requirements.

Contact: +91 9371639228

E-mail: info@KarpsChem.in | bd@KarpsChem.in

Haloperido: Antipsychotic medications

Antipsychotic medications are used as a short-term treatment for bipolar disorder to control psychotic symptoms such as hallucinations, delusions, or mania symptoms. These symptoms may occur during acute mania or severe depression. Some also treat bipolar depression, and several have demonstrated long-term value in preventing future episodes of mania or depression

Haloperidol, marketed under the trade name Haldol among others, is a typical antipsychotic medication. Haloperidol KSM, intermediate and impurities available in KarpsChem ready in stock.

For instant quote log on to: www.karpschem.in

Contact: info@karpschem.in  |  +91-9371639228

Apixaban Impurity 2 and Apixaban Impurity 29

Apixaban, sold under the trade name Eliquis, is an anticoagulant for the treatment of venous thromboembolic events. It is taken by mouth. It is a direct factor Xa inhibitor. Apixaban was approved in Europe in 2012. It was approved in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It was developed in a joint venture by Pfizer and Bristol-Myers Squibb.

Medical uses Apixaban is indicated for the following: To lower the risk of stroke and embolism in patients with non-valvular atrial fibrillation. Deep vein thrombosis (DVT) prophylaxis. DVTs may lead to pulmonary embolism (PE) in knee or hip replacement surgery patients. Treatment of both DVT and PE. To reduce the risk of recurring DVT and PE after initial therapy.

Rare pharmaceutical impurities of Apixaban like Apixaban Impurity 2 and Apixaban Impurity 29 has been successfully developed by KarpsChem R&D team.

#Pfizer #Bristol-Myers Squibb #Drug #Impurity #Eliquis